Sara Tartof to Adult
This is a "connection" page, showing publications Sara Tartof has written about Adult.
Connection Strength
1.007
-
Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System. JAMA Netw Open. 2023 Jan 03; 6(1):e2251833.
Score: 0.090
-
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study. Lancet Respir Med. 2023 Feb; 11(2):176-187.
Score: 0.089
-
Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection. JAMA Netw Open. 2022 08 01; 5(8):e2225657.
Score: 0.088
-
Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 08; 70(40):1415-1419.
Score: 0.083
-
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021 10 16; 398(10309):1407-1416.
Score: 0.083
-
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization. Ann Intern Med. 2020 11 17; 173(10):773-781.
Score: 0.076
-
Antibiotic and antifungal treatment among persons with confirmed coccidioidomycosis - Southern California, 2011. Med Mycol. 2020 Apr 01; 58(3):411-413.
Score: 0.074
-
Safety of Seasonal Influenza Vaccination in Hospitalized Surgical Patients: A Cohort Study. Ann Intern Med. 2016 05 03; 164(9):593-9.
Score: 0.056
-
A Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure. Infect Control Hosp Epidemiol. 2015 Dec; 36(12):1409-16.
Score: 0.054
-
Incidence of polymerase chain reaction-diagnosed Clostridium difficile in a large high-risk cohort, 2011-2012. Mayo Clin Proc. 2014 Sep; 89(9):1229-38.
Score: 0.050
-
Bordetella holmesii bacteremia cases in the United States, April 2010-January 2011. Clin Infect Dis. 2014 Jan; 58(2):e39-43.
Score: 0.047
-
Identifying optimal vaccination strategies for serogroup A Neisseria meningitidis conjugate vaccine in the African meningitis belt. PLoS One. 2013; 8(5):e63605.
Score: 0.046
-
Natural Language Processing for Improved Characterization of COVID-19 Symptoms: Observational Study of 350,000 Patients in a Large Integrated Health Care System. JMIR Public Health Surveill. 2022 12 30; 8(12):e41529.
Score: 0.023
-
Ambient temperature and risk of urinary tract infection in California: A time-stratified case-crossover study using electronic health records. Environ Int. 2022 07; 165:107303.
Score: 0.022
-
Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022. MMWR Morb Mortal Wkly Rep. 2022 Mar 11; 71(10):365-370.
Score: 0.021
-
Identifying patients with symptoms suspicious for COVID-19 at elevated risk of adverse events: The COVAS score. Am J Emerg Med. 2021 Aug; 46:489-494.
Score: 0.019
-
Trends in Acute Myocardial Infarction by Race and Ethnicity. J Am Heart Assoc. 2020 03 03; 9(5):e013542.
Score: 0.019
-
Vaccine safety in HIV-infected adults within the Vaccine Safety Datalink Project. Vaccine. 2019 05 31; 37(25):3296-3302.
Score: 0.017
-
A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol. 2015 Apr; 11(4):e1004138.
Score: 0.013
-
Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases. JAMA Neurol. 2014 Dec; 71(12):1506-13.
Score: 0.013
-
Hepatitis B testing and vaccination among adults with sexually transmitted infections in a large managed care organization. Clin Infect Dis. 2014 Jun; 58(12):1739-45.
Score: 0.012
-
Surgery for valvular heart disease: a population-based study in a Brazilian urban center. PLoS One. 2012; 7(5):e37855.
Score: 0.011